Holen Sie sich die Stockscreener-App
2.29
2.55%
-0.06
Handel nachbörslich:
2.39
0.10
+4.37%
Schlusskurs vom Vortag:
$2.35
Offen:
$2.31
24-Stunden-Volumen:
81,569
Relative Volume:
1.47
Marktkapitalisierung:
$69.82M
Einnahmen:
$4.01M
Nettoeinkommen (Verlust:
$-38.53M
KGV:
-1.8175
EPS:
-1.26
Netto-Cashflow:
$-32.27M
1W Leistung:
-10.89%
1M Leistung:
-13.26%
6M Leistung:
-21.58%
1J Leistung:
-68.84%
1-Tages-Spanne:
$2.28
$2.37
1-Wochen-Bereich:
$2.28
$2.56
52-Wochen-Spanne:
$2.28
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Firmenname
Xbiotech Inc
Sektor
Branche
Telefon
512-386-2900
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Vergleichen Sie XBIT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.29 | 71.65M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-04-21 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-06-28 | Bestätigt | Noble Financial | Buy |
Xbiotech Inc Aktie (XBIT) Neueste Nachrichten
Will XBiotech Inc. (4XB) stock outperform foreign stocksJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Can XBiotech Inc. stock outperform in 2025 bull marketVolume Spike & AI Driven Stock Reports - newser.com
How high can XBiotech Inc. stock go2025 Risk Factors & Long-Term Safe Investment Plans - newser.com
How strong is XBiotech Inc. stock balance sheet2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com
Will XBiotech Inc. stock go up soonIPO Watch & Entry Point Strategy Guides - newser.com
Chart based exit strategy for XBiotech Inc.Trade Analysis Summary & Smart Money Movement Tracker - newser.com
Will XBiotech Inc. (4XB) stock announce a stock split2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Is XBiotech Inc. stock near bottom after declineWeekly Trade Recap & Verified Momentum Watchlists - newser.com
Will XBiotech Inc. stock benefit from infrastructure spending2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Will XBiotech Inc. stock benefit from automationWeekly Investment Report & Safe Capital Growth Tips - newser.com
Will XBiotech Inc. stock continue upward momentum2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Intraday pattern recognizer results for XBiotech Inc.July 2025 PreEarnings & Fast Entry High Yield Tips - newser.com
Can volume confirm reversal in XBiotech Inc.July 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
What risks investors should watch in XBiotech Inc. stock2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Will XBiotech Inc. stock split attract more investorsJuly 2025 Price Swings & Reliable Momentum Entry Alerts - newser.com
XBiotech Inc. stock trend forecastJuly 2025 Reactions & Safe Capital Growth Tips - newser.com
Can XBiotech Inc. (4XB) stock sustain free cash flowJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Is it too late to sell XBiotech Inc.Treasury Yields & AI Powered Market Entry Ideas - newser.com
XBiotech (NASDAQ:XBIT) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
How XBiotech Inc. (4XB) stock trades after rate cutsWeekly Trend Report & Free Growth Oriented Trading Recommendations - newser.com
Earnings visualization tools for XBiotech Inc.2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Will XBiotech Inc. (4XB) stock announce special dividendJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):